Research graph
References from At-home subcutaneous atezolizumab for non-small cell lung cancer: a prospective, single-arm phase II feasibility study. Local targets link to admitted publications; unresolved targets remain external evidence.
10.1016/j.critrevonc.2018.03.011
10.1016/j.critrevonc.2018.03.011 · External reference
Unresolved reference
External reference
10.1007/s00408-020-00407-5
10.1007/s00408-020-00407-5 · External reference
10.1038/nature25183
10.1038/nature25183 · External reference
10.1002/14651858.cd014861
10.1002/14651858.cd014861 · External reference
10.1182/blood-2020-137560
10.1182/blood-2020-137560 · External reference
10.1016/s0140-6736(23)00774-2
10.1016/s0140-6736(23)00774-2 · External reference
10.1136/bmjopen-2022-063242
10.1136/bmjopen-2022-063242 · External reference
10.1016/j.critrevonc.2026.105231
10.1016/j.critrevonc.2026.105231 · External reference
10.1016/j.jddst.2024.105770
10.1016/j.jddst.2024.105770 · External reference
10.1021/acs.molpharmaceut.5c00473
10.1021/acs.molpharmaceut.5c00473 · External reference
10.1016/j.jtocrr.2025.100815
10.1016/j.jtocrr.2025.100815 · External reference
10.1016/j.jtho.2024.05.005
10.1016/j.jtho.2024.05.005 · External reference
